Highlights
About
Immune-based Cancer Treatment
Z.M.D. Medical develops and commercializes a therapeutic remedy designed to treat cancers of all types by using the patients immune system. The companys goal is to produce probiotic preparations to rehabilitate distressed colon microflora in order to eliminate cancer from the immune system and help it recover. Z.M.D. Medicals probiotic ONCARIN consists of a blend of five lyophilized bacteria species, each represented by a single phenotype with maximum oncolytic activity. To preserve the vitality of the bacteria, the drug is enclosed in a capsule that dissolves only after transiting through the stomach with its strong, enteric-coated capsules. The probiotic is designed to prevent the functional state of the immune system from degrading to cancerous conditions and to raise the functional state of a degraded immune system to a normal state, allowing it to eliminate cancer. Z.M.D. Medical is a sister company of Z.M.D. Diagnostics and operates under the Z.M.D. Group (a spin-off of the Tel Hashomer-Sheba TTO).
Identity
| Name | Z.M.D. Medical |
|---|---|
| Slug | z-m-d-medical |
| Type / kind | startup |
| Crunchbase ID | z-m-d-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPWjwpQJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Sep 2021 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Yavne |
| HQ address | Ad'ad 29, Yavne, Israel |
Classifications
Funding
| Total raised | $659K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}